Correction: Structural Basis of Gate-DNA Breakage and Resealing by Type II Topoisomerases

Correction: Structural Basis of Gate-DNA Breakage and Resealing by Type II Topoisomerases

Bibliographic Details
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2010-01-01
Series:	PLoS ONE
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2900311/?tool=EBI

Similar Items

Correction: Structural Basis of Gate-DNA Breakage and Resealing by Type II Topoisomerases
Published: (2010-01-01)

Correction: Structural Basis of Gate-DNA Breakage and Resealing by Type II Topoisomerases.
by: Ivan Laponogov, et al.
Published: (2010-01-01)

Correction: Structural Basis of Gate-DNA Breakage and Resealing by Type II Topoisomerases.
by: Ivan Laponogov, et al.
Published: (2010-01-01)

Structural basis of gate-DNA breakage and resealing by type II topoisomerases.
by: Ivan Laponogov, et al.
Published: (2010-06-01)

Structural insights into the gating of DNA passage by the topoisomerase II DNA-gate
by: Shin-Fu Chen, et al.
Published: (2018-08-01)

What’s on the Other Side of the Gate: A Structural Perspective on DNA Gate Opening of Type IA and IIA DNA Topoisomerases
by: Vita Vidmar, et al.
Published: (2023-02-01)

Structural basis for allosteric regulation of Human Topoisomerase IIα
by: Arnaud Vanden Broeck, et al.
Published: (2021-05-01)

Structural and Biochemical Basis of Etoposide-Resistant Mutations in Topoisomerase IIα
by: Elizabeth G. Gibson, et al.
Published: (2022-06-01)

Structural and biochemical basis for DNA and RNA catalysis by human Topoisomerase 3β
by: Xi Yang, et al.
Published: (2022-08-01)

Resealed Erythrocyte: an Approach to Targeted Drug Delivery
by: Roshani Kumari, et al.
Published: (2018-04-01)

Resealed Erythrocyte: an Approach to Targeted Drug Delivery
by: Roshani Kumari, et al.
Published: (2018-04-01)

Breakage-reunion domain of Streptococcus pneumoniae topoisomerase IV: crystal structure of a gram-positive quinolone target.
by: Ivan Laponogov, et al.
Published: (2007-03-01)

Targeting DNA Topoisomerase II in Antifungal Chemotherapy
by: Kavya Kondaka, et al.
Published: (2022-11-01)

The Roles of DNA Topoisomerase IIβ in Transcription
by: Ram Madabhushi
Published: (2018-06-01)

Antibacterial activity of novel dual bacterial DNA type II topoisomerase inhibitors.
by: Noemi D'Atanasio, et al.
Published: (2020-01-01)

Trapping of the transport-segment DNA by the ATPase domains of a type II topoisomerase
by: Ivan Laponogov, et al.
Published: (2018-07-01)

A Bacterial Chromosome Structuring Protein Binds Overtwisted DNA to Stimulate Type II Topoisomerases and Enable DNA Replication
by: Guo, Monica S, et al.
Published: (2020)

Topoisomerase II- and condensin-dependent breakage of MEC1ATR-sensitive fragile sites occurs independently of spindle tension, anaphase, or cytokinesis.
by: Nadia Hashash, et al.
Published: (2012-01-01)

Activation of SIRT1 promotes membrane resealing via cortactin
by: Naotoshi Iwahara, et al.
Published: (2022-09-01)

Sonoporation generates downstream cellular impact after membrane resealing
by: Xinxing Duan, et al.
Published: (2021-03-01)

Development of topoisomerase I inhibitors on the basis of structural variation of oligonucleotides.
by: Quek, Ngee Mien.
Published: (2011)

Evaluation of Interactions of Selected Olivacine Derivatives with DNA and Topoisomerase II
by: Beata Tylińska, et al.
Published: (2021-08-01)

DNA Double Strand Breaks and Chromosomal Translocations Induced by DNA Topoisomerase II
by: Fernando Gómez-Herreros, et al.
Published: (2019-12-01)

Correction: DNA Topoisomerase II Is Involved in Regulation of Cyst Wall Protein Genes and Differentiation in Giardia lamblia.
by: Bo-Chi Lin, et al.
Published: (2017-01-01)

An Overview of Cell Membrane Perforation and Resealing Mechanisms for Localized Drug Delivery
by: Stephanie He, et al.
Published: (2022-04-01)

Applications of cell resealing to reconstitute microRNA loading to extracellular vesicles
by: Yuki Sonoda, et al.
Published: (2021-02-01)

Inhibitory effects of lapachol on rat C6 glioma in vitro and in vivo by targeting DNA topoisomerase I and topoisomerase II
by: Huanli Xu, et al.
Published: (2016-11-01)

DNA-Topology Simplification by Topoisomerases
by: Andreas Hanke, et al.
Published: (2021-06-01)

Discovery of New DNA Topoisomerase II Inhibitors using Structure Based Virtual Screening Method
by: Tugba Ertan-Bolelli, et al.
Published: (2019-05-01)

The impact of the human DNA topoisomerase II C-terminal domain on activity.
by: Emma L Meczes, et al.
Published: (2008-03-01)

Voreloxin is an anticancer quinolone derivative that intercalates DNA and poisons topoisomerase II.
by: Rachael E Hawtin, et al.
Published: (2010-04-01)

Examining the Impact of Antimicrobial Fluoroquinolones on Human DNA Topoisomerase IIα and IIβ
by: Cole A. Fief, et al.
Published: (2019-02-01)

Impairment of Ceramide-Mediated Endothelial Instant Membrane Resealing During Diabetes Mellitus
by: Yang Chen, et al.
Published: (2022-07-01)

Genetic modifiers of muscular dystrophy act on sarcolemmal resealing and recovery from injury.
by: Mattia Quattrocelli, et al.
Published: (2017-10-01)

Membrane transport of anandamide through resealed human red blood cell membranes
by: Inge N. Bojesen, et al.
Published: (2005-08-01)

SIRT1 deficiency interferes with membrane resealing after cell membrane injury.
by: Daisuke Fujiwara, et al.
Published: (2019-01-01)

Road experiments to compare the performance of paving bitumens in reseals: victoria 1973-1974
by: 354694 Dickinson, E. J.
Published: (1976)

Molecular basis for processing of topoisomerase 1-triggered DNA damage by Apn2/APE2
by: Jessica S. Williams, et al.
Published: (2022-10-01)

Novel DNA topoisomerase IIα inhibitors from combined ligand- and structure-based virtual screening.
by: Malgorzata N Drwal, et al.
Published: (2014-01-01)

The impact of the C-terminal domain on the interaction of human DNA topoisomerase II α and β with DNA.
by: Kathryn L Gilroy, et al.
Published: (2011-01-01)